Veru (VERU) surges 161.8% after disclosing Novo Nordisk Wegovy supply deal for obesity study - Quiver Quantitative
Veru (VERU) surges 161.8% after disclosing Novo Nordisk Wegovy supply deal for obesity study Quiver Quantitative
Veru (VERU) surges 161.8% after disclosing Novo Nordisk Wegovy supply deal for obesity study Quiver Quantitative
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.